PGRx : Graves' disease FRESH-PEF2634-en Elodie AUBRUN PGRx : Graves' disease FRESH-PEF2634-en 2634 FRESH-PEF2634 Lamiae GRIMALDI-BENSOUDA L.A. SANTE EPIDEMIOLOGIE EVALUATION RECH Epidemiology France Portal (PEF) L.A. SANTE EPIDEMIOLOGIE EVALUATION RECH null Lamiae;GRIMALDI-BENSOUDA Graves pharmaco-epidemiology Internal medicine Paediatrics Endocrinology Thyrotoxicosis with diffuse goitre Surveillance and assessment of the risk of Graves' disease associated with drug or vaccine use in real life situations. null France Individuals General population Male Female Infant, Newborn (birth to 28 days) Infant (28 days to 2 years) Child, Preschool (2 to 5 years) Child (6 to 12 years) Young Adult (19 to 24 years) Adult (25 to 44 years) Middle Aged (45 to 64 years) For the cases: patients, males and females aged 0 to 49 years, having clinical or biological signs or symptoms suggesting Graves' disease declared by the specialist, for which the first symptoms of the episode occurred less than 12 months ago. For the controls: patients, males and females aged 0 to 49 years and older, having consulted a general practitioner. Clinical data Participant-reported health data Health event/morbidity Other Through independent healthcare practitioners Through organizations (health services or institutions schools businesses etc.) [10000-20000[ individuals Converting or copying information into a structured record Interview with the participant (including clinical) Observational Study Observational Study Case-control study - 153 cas/cases - 11125 référents/controls Unknown To be defined Access on specific project only